STOCK TITAN

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Cybin Inc. announced its participation in the upcoming Public Ventures Discovery Day on March 19, 2024, where Doug Drysdale, the CEO, will engage in a fireside chat. The event aims to showcase Cybin's innovative psychedelic-based treatment options.
Positive
  • None.
Negative
  • None.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced participation in the upcoming Public Ventures Discovery Day on March 19, 2024 in Dallas, TX.

Doug Drysdale, Chief Executive Officer of Cybin will participate in a fireside chat at the event and will be available to meet attendees during breakout sessions.

Public Ventures Discovery Day

Date:

 

Tuesday, March 19, 2024

Presentation:

 

3:05 PM CT

Location:

 

Pecan Room, Old Parkland, 3819 Maple Avenue, Dallas TX 75219

A video replay of the fireside chat will be available shortly after the conclusion of the event on the Company’s investor relations website on the Events & Presentations page.

Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, (NASDAQ: MDBH), is the first invite-only investor community and self-clearing broker-dealer platform dedicated to backing visionary public companies with the potential to become market leaders in their technology category.

Discovery Day is a unique event for investors to learn about a curated group of venture-stage, deep-tech companies; share feedback and questions with company leaders; and connect with like-minded investors.

To register for Discovery Day, please email community@publicventures.com. Please note that spots are limited, and attendance preference will be given to existing MDBH shareholders.

About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.

Investor & Media Contact:

Gabriel Fahel

Chief Legal Officer

Cybin Inc.

1-866-292-4601

irteam@cybin.com – or – media@cybin.com

Source: Cybin Inc.

FAQ

When is Cybin Inc. participating in the Public Ventures Discovery Day?

Cybin Inc. is participating in the Public Ventures Discovery Day on March 19, 2024.

Who will engage in a fireside chat at the event?

Doug Drysdale, the Chief Executive Officer of Cybin, will participate in a fireside chat at the event.

What is the purpose of the Public Ventures Discovery Day event?

The event aims to showcase Cybin's innovative next-generation psychedelic-based treatment options.

What is the location and time of the presentation?

The presentation will take place at 3:05 PM CT in the Pecan Room, Old Parkland, 3819 Maple Avenue, Dallas TX 75219.

Who is Public Ventures, , and what is their connection to Cybin Inc.?

Public Ventures, , a subsidiary of MDB Capital Holdings, , is an investor community dedicated to supporting visionary public companies like Cybin.

Where can a video replay of the fireside chat be accessed?

A video replay will be available on the Company's investor relations website on the Events & Presentations page.

Cybin Inc.

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Stock Data

185.23M
18.64M
6.35%
36.61%
3.05%
Biotechnology
Healthcare
Link
United States of America
Toronto